Stage-Dependent Expression of Hormonal Receptors, HER2, Ki-67, and PD-L1 in Breast Cancer: Correlation With Molecular Subtypes and Tumor Microenvironment
Tumor stage and molecular phenotype are both powerful predictors of the clinical behavior and therapeutic responsiveness of breast cancer. Although the most commonly used IHC biomarkers, including ER, PR, HER2, Ki-67, and PD-L1, are actively applied in practice, the dynamics of their integration and their connection wi...